We have introduced the examination of selected genes using MLPA method (Multiplex Ligation-dependent Probe Amplification = “multiplication of many ligated probes”). This method reveals large gene rearrangements by measuring the number of copies of individual gene segments. In this manner it is possible to identify such mutations, which can not be found in another way.
Newly we provide molecular genetic testing of the BRCA1 and BRCA2 genes. Changes (mutations) in these genes are the most significant genetic cause of increased risk of breast and ovarian cancer, and to a lesser extent also of cancer of other organs.
Company GENvia,s.r.o. changes and unifies the existing graphical form of used documents, including the company logo. Step by step they will be updated and replaced all the valid forms.
Based on the result of the inspectional audit, SÚKL prolonged the Work permit of the diagnostic laboratory GENvia.
Because of the full transition to the domain genvia.cz were the e-mail addresses changed as follows:
Financial accounting department:
The original addresses (firstname.lastname@example.org and email@example.com) remain further active and will be redirected to the new mailboxes.
We opened for our clients a new genetic clinic in Hloubetín. Contact information can be found in the section Contacts.